Improving outcomes in chronic myeloid leukemia through harnessing the immunological landscape | Leukemia
Cancers | Free Full-Text | Early T-Cell Precursor ALL and Beyond: Immature and Ambiguous Lineage T-ALL Subsets | HTML
Diagnostic and predictive biomarkers for lymphoma diagnosis and treatment in the era of precision medicine | Modern Pathology
Epigenomics of leukemia: from mechanisms to therapeutic applications | Epigenomics
Frontiers | Immune Dysfunctions and Immune-Based Therapeutic Interventions in Chronic Lymphocytic Leukemia
Frontiers | Chronic Lymphocytic Leukemia B-Cell Normal Cellular Counterpart: Clues From a Functional Perspective
Molecular and cellular markers for measurable residual disease in acute lymphoblastic leukemia
Acute myeloid leukemia: 2019 update on risk‐stratification and management - Estey - 2018 - American Journal of Hematology - Wiley Online Library
Predictive value of inflammatory markers for cancer diagnosis in primary care: a prospective cohort study using electronic health records | British Journal of Cancer
Childhood Acute Myeloid Leukemia/Other Myeloid Malignancies Treatment (PDQ®)–Health Professional Version - NCI
Restoring Specific Lactobacilli Levels Decreases Inflammation and Muscle Atrophy Markers in an Acute Leukemia Mouse Model | PLOS ONE
Midostaurin reduces Regulatory T cells markers in Acute Myeloid Leukemia | Scientific Reports
Molecular and cellular markers for measurable residual disease in acute lymphoblastic leukemia
Immune-Based Therapies in Acute Leukemia: Trends in Cancer
IJMS | Free Full-Text | Ampelopsin Inhibits Cell Proliferation and Induces Apoptosis in HL60 and K562 Leukemia Cells by Downregulating AKT and NF-κB Signaling Pathways | HTML
Molecular and cellular markers for measurable residual disease in acute lymphoblastic leukemia
Frontiers | Acute Myeloid Leukemia: From Biology to Clinical Practices Through Development and Pre-Clinical Therapeutics
T-cells in chronic lymphocytic leukemia: Guardians or drivers of disease? | Leukemia
Altered Levels of Neonatal Inflammatory Markers Linked to Childhood Leukemia Development
Chronic lymphocytic leukemia - Wikipedia
Strong inflammatory response and Th1-polarization profile in children with acute lymphoblastic leukemia without apparent infection
Chronic Lymphocytic Leukemia Treatment (PDQ®)–Patient Version - NCI
Chronic Lymphocytic Leukemia Treatment (PDQ®)–Patient Version - NCI
Kinetics of inflammatory markers during late release syndrome 15 days... | Download Scientific Diagram
Frontiers | Clinical Implications of Inflammation in Acute Myeloid Leukemia
Levels of epigenetic heterochromatin markers in leukemia blood cells.... | Download Scientific Diagram
Radical treatment for leukemia under way
Pre-treatment blood inflammatory markers as predictors of systemic infection during induction chemotherapy: results of an exploratory study in patients with acute myeloid leukemia | SpringerLink
